Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 89 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 8481024

    Vaccines against tularemia

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  2. US 8476043

    Inhibitors for the soluble epoxide hydrolase

    The Regents of the University of California · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  3. US 8476451

    Tubulysin D analogues

    The Regents of the University of California · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  4. US 8470545

    Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

    The Regents of the University of California · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  5. US 8461298

    Compositions and methods for modification of biomolecules

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  6. US 8460651

    Methods of treating amyotrophic lateral sclerosis (ALS)

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  7. US 8460653

    Superoxide dismutase variants and methods of use thereof

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  8. US 8455553

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease and transplant rejection

    The Regents of the University of California · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  9. US 8454958

    Methods for detecting and inhibiting angiogenesis

    The Regents of the University of California · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  10. US 8450481

    Compounds for inhibiting protein aggregation, and methods for making and using them

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  11. US 8450062

    SOCS-3 promoter methylation in cancer

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  12. US 8449875

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  13. US 8445507

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  14. US 8445021

    Functionalized magnetic nanoparticles and methods of use thereof

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  15. US 8445632

    Selective poly-N-substituted glycine antibiotics

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  16. US 8440621

    Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

    The Regents of the University of California · Granted May 14, 2013 · Expires May 9, 2033

    granted

  17. US 8440229

    Hollow silica nanospheres and methods of making same

    The Regents of the University of California · Granted May 14, 2013 · Expires May 9, 2033

    granted

  18. US 8435941

    Mini-hepcidin peptides and methods of using thereof

    The Regents of the University of California · Granted May 7, 2013 · Expires May 2, 2033

    granted

  19. US 8431558

    Compositions and methods for modification of biomolecules

    The Regents of the University of California · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  20. US 8431561

    Methods and compositions for treatment of excess nitric oxide or cyanide toxicity

    The Regents of the University of California · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  21. US 8425930

    Prebiotic oligosaccharides

    The Regents of the University of California · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  22. US 8420612

    Diabetes treatment methods and drug targets therefor

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  23. US 8420852

    Phospholipase A2 inhibitors and their use in treating neurological injury and disease

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  24. US 8415293

    Peptide mediators of cholesterol efflux

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.